QUINLAN KEVIN W 4
4 · ANIKA THERAPEUTICS INC · Filed Mar 4, 2013
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2013-02-27$6.99/sh+5,000$34,950→ 20,744 total - Exercise/Conversion
Common Stock
2013-02-27$6.99/sh+6,368$44,512→ 27,112 total
Footnotes (1)
- [F1]The stock options were issued under a Performance Grant on June 7, 2011, the date the Compensation Committee of the Company determined that certain performance measures governing the Performance Grant were achieved. The stock options vest in three equal installments as follows: March 1, 2012, January 1, 2013, and January 1, 2014.